Tag: Drug

Fast-tracking drug development for neurodegenerative disorders

A Griffith University-led research team has discovered how a therapeutic target common among debilitating neurodegenerative disorders is activated, which could help accelerate drug development. In a study published in the journal Neuron, the researchers from Griffith University’s Institute for Glycomics, the University of Queensland and Washington University, analyzed the structure and function of a protein

Anticancer drug may improve outcome for severe COVID-19 patients

Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet in Sweden between February and April 2020. On average, blood oxygen levels, body temperature and inflammatory markers significantly improved in patients

Common drug colchicine brings hope to COVID fight: Canadian research

A major clinical trial in Canada shows that an inexpensive anti-inflammatory drug called colchicine can significantly reduce the risk of complications and death from COVID-19, bringing “important hope” to sufferers, the lead researcher said Sunday. Jean-Claude Tardif, head of the Montreal Heart Institute (ICM), led the study named “Colcorona,” whose preliminary results were published Friday

Lilly: Drug can prevent COVID-19 illness in nursing homes

Drugmaker Eli Lilly said Thursday its antibody drug can prevent COVID-19 illness in residents and staff of nursing homes and other long-term care locations. It’s the first major study to show such a treatment may prevent illness in a group that has been devastated by the pandemic. Residents and staff who got the drug had

Living macrophage-based drug promotes antitumor immunotherapy

Immunotherapy is one of the most promising approaches to inhibit tumor growth and metastasis by activating host immune functions. However, so far, immunotherapy still exhibits limitations of efficacy and safety, such as huge individual differences in treatment responses, difficulty to work on solid tumors, systemic immune storm and other immunotoxicity. Therefore, the development of advanced

Newer Rheumatoid Arthritis Drug, Upadacitinib (Rinvoq), May Help Ease Tough-to-Treat Cases

MONDAY, Oct. 19, 2020 — A recently approved rheumatoid arthritis medication appears to be an effective second-line therapy when biologic treatments start to fail, a new clinical trial reports. Arthritis sufferers treated with upadacitinib had a significantly greater reduction in their symptoms and disease activity than people treated with a standard disease-modifying antirheumatic drug (DMARD),

Lilly's rheumatoid arthritis drug cuts COVID-19 deaths in trial,…

Arthritis drug improves survival odds for COVID-19 patients treated with remdesivir by 35%, NIH study finds An NIH trial tested a combination of Eli Lilly’s arthritis drug, barcitinib, and the antiviral  remdesivir to treat COVID-19  Overall, those who got both drugs were 35% more likely to survive than those given remdesivir alone  People on supplemental

Millimetre-precision drug delivery to the brain

Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable. Today, this is practically impossible—drugs traveling through

No benefit from drug used to reduce heart disease in kidney patients

Following a large-scale clinical trial, researchers have found that lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease. The drug is routinely prescribed to patients with chronic kidney disease to help reduce the risk of both bone disease and cardiovascular disease, with cardiovascular disease the most common

Prescription monitoring may curb inappropriate drug use, but what happens to those denied a script?

Restricting access to high-risk medications via a real-time prescription monitoring program such as Victoria’s SafeScript may help reduce inappropriate use, but integrated mental health and drug treatment services may be necessary to offset the risk of increased mortality, according to the authors of a letter published online by the Medical Journal of Australia. Researchers from

COVID-19: Lower risk of death in treatment with medication for heartburn – natural healing naturopathic specialist portal

Study shows potential of heartburn drug for COVID-19 According to an observational study, which was conducted at Irving, Medical Center of Columbia University (USA), could help a common drug for heartburn by the Coronavirus SARS-CoV-2-induced disease COVID-19. In a new study has shown that COVID-19-patients and in -patients in the Famotidine, a common drug for

Russia to treat virus cases with anti-malaria drug

The Russian government has authorised the use of an anti-malarial drug to treat coronavirus patients despite international concerns over its safety and effectiveness. The government published an order late Thursday allowing the use of hydroxychloroquine on patients after China donated more than 68,000 packs of the tablets to Russia. The order was published after President

Trump wrongly claims FDA drug is approved to treat coronavirus

Trump claims an anti-malaria drug is APPROVED to treat coronavirus – but is corrected by the FDA head who says it is still ‘experimental’ and will be studied in some American patients President Trump said in a Thursday press conference that the anti-malaria drug hydroxychloroquine had been FDA-approved to treat coronavirus patients  FDA Commissioner Stephen